Ocumension Therapeutics

HKEX:1477.HK

5.43 (HKD) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 842.8391,053.801537.0441,039.8471,170.0491,314.4471,572.2931,574.8931,125.2211,785.2212,259.092,283.3742,034.3192,051.819755.277755.277192.404750.5-91.897
Short Term Investments 206.6620478.9030118.39800064000000292.421292.4211,055.749497.653183.794
Cash and Short Term Investments 1,049.5011,053.8011,015.9471,039.8471,288.4471,314.4471,572.2931,574.8931,765.2211,785.2212,259.092,283.3742,034.3192,051.8191,047.6981,047.6981,248.1531,248.15391.897
Net Receivables 97.747119.36122.60366.154138.711112.71197.40762.54518.50918.5098.8198.8197.817.811.8051.8050.0960.0960
Inventory 32.47332.47328.91228.91224.10424.10423.82223.8224.9934.9932.3092.3093.0273.0270.2370.2370.2590.2590
Other Current Assets 21.61303.74736.2963.8983.8983.93336.19564.35325.84462.99162.99166.05840.74824.94723.14213.581511.1380
Total Current Assets 1,205.6341,205.6341,171.2091,171.2091,455.161,455.161,697.4551,697.4551,834.5671,834.5672,357.4932,357.4932,103.4042,103.4041,072.8821,072.8821,261.9931,261.99391.897
Non-Current Assets:
Property, Plant & Equipment, Net 467.651467.651445.653445.653448.069448.069435.939435.939365.862365.862164.17164.1782.02582.0255.3365.3362.0152.0150
Goodwill 0000000000000000000
Intangible Assets 1,140.1811,140.1811,027.4911,027.491919.05919.05802.513802.513709.973709.973354.612354.612201.65225.77657.59757.59725250
Goodwill and Intangible Assets 1,140.1811,140.1811,027.4911,027.491919.05919.05802.513802.513709.973709.973354.612354.612201.65225.77657.59757.59725250
Long Term Investments 364.148364.148-265.478213.425-23.39895201.055201.055-367.599272.401243.137243.1370000000
Tax Assets 00606.501023.3980-201.055000-243.13700000000
Other Non-Current Assets 93.38593.38515.583143.181221.395126.395331.575130.52788.25148.25403.899160.762212.481388.357109.841109.8410.6890.689-91.897
Total Non-Current Assets 2,065.3652,065.3651,829.751,829.751,588.5141,588.5141,570.0271,570.0271,496.4861,496.486922.681922.681496.158496.158172.774172.77427.70427.704-91.897
Total Assets 3,270.9993,270.9993,000.9593,000.9593,043.6743,043.6743,267.4823,267.4823,331.0533,331.0533,280.1743,280.1742,599.5622,599.5621,245.6561,245.6561,289.6971,289.6970
Liabilities & Equity:
Current Liabilities:
Account Payables 25.19225.19214.81314.81321.70321.7038.3188.3184.4074.4071.4971.4979.3439.3431.4961.4963.943.940
Short Term Debt 132.32612013.125012.285015.34504.18604.10701.92700.59101.25900
Tax Payables 2.27101.4201.54600.83302.39901.46501.43900.39100.200
Deferred Revenue -12.32600000000000-1.9270-0.5910-1.25900
Other Current Liabilities 170.092170.092185.838198.963213.665225.95235.722251.067207.261211.447116.181120.28882.58282.58255.08355.08335.49535.4950
Total Current Liabilities 315.284315.284213.776213.776247.653247.653259.385259.385215.854215.854121.785121.78591.92591.92556.57956.57939.43539.4350
Non-Current Liabilities:
Long Term Debt 5.6575.65711.3311.3317.29217.29225.16925.1697.0267.0268.438.435.3095.3094,830.4314,830.4313,318.753,318.750
Deferred Revenue Non-Current 30.09030.09030.09030.09000000000000
Deferred Tax Liabilities Non-Current -30.090-30.090-30.090-30.09000000000000
Other Non-Current Liabilities 30.0930.0930.0930.0930.0930.0930.0930.0900000000000
Total Non-Current Liabilities 35.74735.74741.4241.4247.38247.38255.25955.2597.0267.0268.438.435.3095.3094,830.4314,830.4313,318.753,318.750
Total Liabilities 351.031351.031255.196255.196295.035295.035314.644314.644222.88222.88130.215130.21597.23497.2344,887.014,887.013,358.1853,358.1850
Equity:
Preferred Stock 0048.3840232.4360163.78504,247.34204,145.39403,784.5603,643.9102,070.58300
Common Stock 0.0480.0480.0480.0480.0480.0480.0460.0460.0460.0460.0440.0440.0410.0410.0060.0060.0040.0040
Retained Earnings -4,721.578-4,721.578-4,655.049-4,655.049-4,446.714-4,446.714-4,236.74-4,236.74-4,044.549-4,044.549-3,854.169-3,854.169-3,784.56-3,784.56-3,261.689-3,261.689-1,519.919-1,519.9190
Accumulated Other Comprehensive Income/Loss 2,919.9215.952-48.384-48.384-232.436-315.795-163.785-163.785-202.793-202.793-291.225-291.225-1.979-258.685-382.221-382.221-550.664-550.664-821.096
Other Total Stockholders Equity 4,721.5787,625.5467,400.7647,449.1487,195.3057,511.17,189.5327,353.3173,108.1277,355.4693,149.9157,295.3092,504.2666,545.532-3,641.362.55-2,068.4922.09143.792
Total Shareholders Equity 2,919.9682,919.9682,745.7632,745.7632,748.6392,748.6392,952.8382,952.8383,108.1733,108.1733,149.9593,149.9592,502.3282,502.328-3,641.354-3,641.354-2,068.488-2,068.488-777.304
Total Equity 2,919.9682,919.9682,745.7632,745.7632,748.6392,748.6392,952.8382,952.8383,108.1733,108.1733,149.9593,149.9592,502.3282,502.328-3,641.354-3,641.354-2,068.488-2,068.488-777.304
Total Liabilities & Shareholders Equity 3,270.9993,270.9993,000.9593,000.9593,043.6743,043.6743,267.4823,267.4823,331.0533,331.0533,280.1743,280.1742,599.5622,599.5621,245.6561,245.6561,289.6971,289.697-777.304